EuroIntervention PCRonline - Connecting with the community

Christian W. Hamm

23 articles

Impact of presentation and transfer delays on complete ST segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial

EuroIntervention 2017; just accepted article published in January 2017

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

EuroIntervention 2016;12:1239-1245 published online ahead of print November 2015

Published in Volume 12 Number 10, November 2016

Implantation of a novolimus-eluting bioresorbable scaffold with a strut thickness of 100 µm showing evidence of self-correction

EuroIntervention 2015;11:204 published online ahead of print February 2015

Published in Volume 11 Number 2, June 2015

2014 ESC/EACTS Guidelines on myocardial revascularization

EuroIntervention 2015;10:1024-1094  published online ahead of print September 2014

Published in Volume 10 Number 9, January 2015

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

EuroIntervention 2014;10:850-859

Published in Volume 10 Number 7, November 2014

Predictors of recurrent stroke after percutaneous closure of patent foramen ovale

EuroIntervention 2014;9:1418-1422

Published in Volume 9 Number 12, April 2014

Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay

EuroIntervention 2011;7:442-448

Published in Volume 7 Number 4, August 2011

Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI

EuroIntervention 2011;7:437-441

Published in Volume 7 Number 4, August 2011

Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry

EuroIntervention 2011;7:201-208

Published in Volume 7 Number 2, June 2011

Head-to-head comparison of Everolimus- vs. Zotarolimus- and Sirolimus-eluting stents: one-year clinical outcomes from the ProEnCy registry

Published in Volume 7 Supplement M, May 2011

Pre-hospital administration of tirofiban in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: a sub-analysis of the On-Time 2 trial

EuroIntervention 2010;6:336-342 - DOI10.4244/EIJV6I3A56

Published in Volume 6 Number 3, August 2010

Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

EuroIntervention 2010;5:962-967

Published in Volume 5 Number 8, April 2010

Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II)

EuroIntervention 2009;5:190:196

Published in Volume 5 Number 2, June 2009

Five-year clinical outcomes of the arterial revascularisation therapies (ARTS-II) study of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions

Published in Volume 5 Supplement E, May 2009

Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II

EuroInterv.2009;4:492-501

Published in Volume 4 Number 4, January 2009

Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

EuroInterv.2008;3:450-459

Published in Volume 3 Number 4, January 2008

Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study design

EuroIntervention 2007;3:371-380 - DOI10.4244/EIJV3I3A67

Published in Volume 3 Number 3, November 2007

A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategy

EuroIntervention 2007;3:228-234 - DOI10.4244/EIJV3I2A39

Published in Volume 3 Number 2, August 2007

Two-year results of a durable polymer everolimus-eluting stent in de novo coronary artery stenosis (The SPIRIT FIRST Trial)

EuroInterv.2007;3:206-212

Published in Volume 3 Number 2, August 2007

The sirolimus-eluting coronary stent in clinical practice: impact of direct stenting versus stenting with balloon pre-dilatation

EuroIntervention 2007;2:459-466 - DOI10.4244/EIJV2I4A82

Published in Volume 2 Number 4, February 2007

One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings
(The SPIRIT FIRST Trial)

EuroInterv.2005;1:266-272

Published in Volume 1 Number 3, November 2005

Arterial Revascularisation Therapies Study Part II - Sirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions

EuroIntervention 2005;1:147-156 - DOI10.4244/EIJV1I2A25

Published in Volume 1 Number 2, August 2005

A randomized comparison of a durable polymer

EuroIntervention 2005;1:58-65 - DOI10.4244/EIJV1I1A07

Published in Volume 1 Number 1, May 2005